Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05989529

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥ 18 years old
  • Clinical diagnosis of Borderline Personality Disorder
  • Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

  • No diagnosis of Borderline Personality Disorder confirmed
  • Inability to perform regular electronic reporting
  • Patient does not understand, sign, and return consent form

Treatment and study plan

Primary outcomes

  1. Number of patients who decide to enroll in a borderline personality disorder clinical research

    Time frame: 3 months

  2. Rate of patients who remain in borderline personality disorder clinical research to trial completion

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Uncovering Clinical Trial Engagement Among Individuals With Borderline Personality Disorder

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Aug 14, 2023
Registry last updated
Aug 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.